MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.70 +0.25 (+2.18%)
At close: Sep 30, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Treasury Shares (2021 - 2022)

Updated

MoonLake Immunotherapeutics (MLTX) posted Treasury Shares of $6,202 for Q4 2021.

Analysis

MoonLake Immunotherapeutics (MLTX) Treasury Shares (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 711.62 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 77.11 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.11 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -49.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 765,483.00
Dec 31, 2021 1.94 Mn
API Access

MoonLake Immunotherapeutics Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=MLTX&period=max&api_key=YOUR_API_KEY